RAPT Latest Press Releases, Rapt Therapeutics, Inc. Corporate News

Releases

57.92

+0.21%

0.12

All
Financials
Insiders

10-Q | RAPT Therapeutics, Inc.(0001673772)
08/08/2024 04:12
8-K | RAPT Therapeutics, Inc.(0001673772)
08/08/2024 04:06
8-K | RAPT Therapeutics, Inc.(0001673772)
07/19/2024 13:25
4 | RAPT Therapeutics, Inc.(0001673772)
05/23/2024 14:20
4 | RAPT Therapeutics, Inc.(0001673772)
05/23/2024 14:19
4 | RAPT Therapeutics, Inc.(0001673772)
05/23/2024 14:17
4 | RAPT Therapeutics, Inc.(0001673772)
05/23/2024 14:15
4 | RAPT Therapeutics, Inc.(0001673772)
05/23/2024 14:14
4 | RAPT Therapeutics, Inc.(0001673772)
05/23/2024 14:11
8-K | RAPT Therapeutics, Inc.(0001673772)
05/23/2024 12:56
10-Q | RAPT Therapeutics, Inc.(0001673772)
05/09/2024 04:09
8-K | RAPT Therapeutics, Inc.(0001673772)
05/09/2024 04:04
DEFA14A | RAPT Therapeutics, Inc.(0001673772)
04/05/2024 12:12
DEF 14A | RAPT Therapeutics, Inc.(0001673772)
04/05/2024 12:08
4 | RAPT Therapeutics, Inc.(0001673772)
04/01/2024 14:54
4 | RAPT Therapeutics, Inc.(0001673772)
04/01/2024 14:52
4 | RAPT Therapeutics, Inc.(0001673772)
04/01/2024 14:50
S-8 | RAPT Therapeutics, Inc.(0001673772)
03/07/2024 11:18
10-K | RAPT Therapeutics, Inc.(0001673772)
03/07/2024 03:10
8-K | RAPT Therapeutics, Inc.(0001673772)
03/07/2024 03:04
8-K | RAPT Therapeutics, Inc.(0001673772)
02/22/2024 12:15
8-K | RAPT Therapeutics, Inc.(0001673772)
02/20/2024 11:32
SC 13G/A | RAPT Therapeutics, Inc.(0001673772)
02/14/2024 12:06
SC 13G/A | RAPT Therapeutics, Inc.(0001673772)
02/14/2024 11:48
SC 13G/A | RAPT Therapeutics, Inc.(0001673772)
02/14/2024 05:05
SC 13G/A | RAPT Therapeutics, Inc.(0001673772)
02/14/2024 03:53
SC 13G | RAPT Therapeutics, Inc.(0001673772)
02/13/2024 12:53
SC 13G/A | RAPT Therapeutics, Inc.(0001673772)
02/09/2024 04:51
4 | RAPT Therapeutics, Inc.(0001673772)
02/01/2024 15:49
4 | RAPT Therapeutics, Inc.(0001673772)
02/01/2024 15:47
4 | RAPT Therapeutics, Inc.(0001673772)
02/01/2024 15:44
4 | RAPT Therapeutics, Inc.(0001673772)
02/01/2024 15:41
SC 13G/A | RAPT Therapeutics, Inc.(0001673772)
01/26/2024 11:26
SC 13G/A | RAPT Therapeutics, Inc.(0001673772)
01/23/2024 05:20
4 | RAPT Therapeutics, Inc.(0001673772)
01/08/2024 12:51
144 | RAPT Therapeutics, Inc.(0001673772)
01/05/2024 10:14
4 | RAPT Therapeutics, Inc.(0001673772)
01/02/2024 11:30
4 | RAPT Therapeutics, Inc.(0001673772)
12/22/2023 09:32
144 | RAPT Therapeutics, Inc.(0001673772)
12/21/2023 05:48
4 | RAPT Therapeutics, Inc.(0001673772)
11/29/2023 09:30
144 | RAPT Therapeutics, Inc.(0001673772)
11/28/2023 06:28
10-Q | RAPT Therapeutics, Inc.(0001673772)
11/13/2023 03:24
8-K | RAPT Therapeutics, Inc.(0001673772)
11/13/2023 03:11
8-K | RAPT Therapeutics, Inc.(0001673772)
11/03/2023 08:04
SC 13G | RAPT Therapeutics, Inc.(0001673772)
10/23/2023 12:42
4 | RAPT Therapeutics, Inc.(0001673772)
10/04/2023 14:30
144 | RAPT Therapeutics, Inc.(0001673772)
10/03/2023 12:24
UPLOAD | RAPT Therapeutics, Inc.(0001673772)
09/15/2023 06:46
CORRESP | RAPT Therapeutics, Inc.(0001673772)
09/15/2023 06:46
4 | RAPT Therapeutics, Inc.(0001673772)
08/22/2023 08:20

Webull provides the latest Rapt Therapeutics, Inc. (RAPT) stock and general news. This information may help you make smarter investment decisions.

About RAPT

RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapies for patients living with inflammatory and immunological diseases. Its lead drug candidate, RPT904, is a half-life extended monoclonal antibody (mAb) designed to bind free human immunoglobin E (IgE), which is being developing for the treatment of food allergy, chronic spontaneous urticaria (CSU) and potentially other inflammatory diseases. The Company’s oncology drug candidate, tivumecirnon, is an oral small-molecule C-C motif chemokine receptor 4 (CCR4) antagonist designed to selectively inhibit the migration of immunosuppressive regulatory T cells (Treg) into tumors.